StratifiA

StratifAI develops AI-driven diagnostic tools aimed at improving precision medicine in oncology. By analyzing medical imaging, pathology data, and clinical information, the company builds predictive biomarkers that help identify patient subgroups and guide treatment strategies. Its platform is designed to accelerate biomarker discovery while supporting pharmaceutical research and clinical decision-making. StratifAI’s broader ambition is to enable more personalized cancer care by transforming complex medical data into actionable insights for clinicians and researchers.